Delivery Order SPE2DB22D3016-SPE2DB25FAUR4
Award Date 4/24/25
Potential Completion Date 5/15/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $17,344.30 to AmerisourceBergen Drug Corp for the supply of Andexxa 200 mg vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.15 to AmerisourceBergen Drug Corp for Andexxa 200 mg vials, with a completion date of July 1, 2025. This competitive, non-set-aside award reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in military and federal healthcare settings. The contract is valued at $6,931.53 with a firm fixed price structure and completion deadline of October 1, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $6,931.53 delivery order to AmerisourceBergen Drug Corp for 200 mg vials of Andexxa, an antidote used to reverse the anticoagulant effects of certain blood thinners. This firm fixed-price contract, issued on July 2, 2025, with an ultimate completion date of July 24, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $6,931.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Andexxa 200 mg vials, with an ultimate completion date of October 9, 2025. This non-set-aside contract represents a specific pharmaceutical procurement under the company's broader federal medical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for ANDEXXA 200 MG VIALS. The $20,794.59 firm fixed price contract has a completion date of July 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,726.12 firm-fixed-price contract is for the supply of 4,567,955,833 units of the medication ANDEXXA 200 MG VIALS. The award has an ultimate completion date of May 8, 2025 and was made on April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support...
- The Defense Logistics Agency (DLA) has awarded a $6,658.73 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. government has awarded a delivery order contract worth $15,050.28 to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product ANDEXXA 200 MG VIALS. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of...
- This federal contract award, valued at $14,801.16, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The contract is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corporation and DLA, valued at up to $999,999,999.00 and running through December 31, 2025....